Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

TerrAscend Corp.

TRSSFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.72
$-0.23(-11.79%)
U.S. Market opens in 17h 18m

TerrAscend Corp. Fundamental Analysis

TerrAscend Corp. (TRSSF) shows weak financial fundamentals with a PE ratio of -6.37, profit margin of -31.21%, and ROE of -68.12%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.14

Areas of Concern

ROE-68.12%
We analyze TRSSF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -86.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-86.6/100

We analyze TRSSF's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRSSF struggles to generate sufficient returns from assets.

ROA > 10%
-14.59%

Valuation Score

Excellent

TRSSF trades at attractive valuation levels.

PE < 25
-6.37
PEG Ratio < 2
-0.14

Growth Score

Weak

TRSSF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TRSSF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.48
Current Ratio > 1
1.38

Profitability Score

Weak

TRSSF struggles to sustain strong margins.

ROE > 15%
-6812.00%
Net Margin ≥ 15%
-31.21%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRSSF Expensive or Cheap?

P/E Ratio

TRSSF trades at -6.37 times earnings. This suggests potential undervaluation.

-6.37

PEG Ratio

When adjusting for growth, TRSSF's PEG of -0.14 indicates potential undervaluation.

-0.14

Price to Book

The market values TerrAscend Corp. at 5.23 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.23

EV/EBITDA

Enterprise value stands at 20.48 times EBITDA. This signals the market has high growth expectations.

20.48

How Well Does TRSSF Make Money?

Net Profit Margin

For every $100 in sales, TerrAscend Corp. keeps $-31.21 as profit after all expenses.

-31.21%

Operating Margin

Core operations generate 16.13 in profit for every $100 in revenue, before interest and taxes.

16.13%

ROE

Management delivers $-68.12 in profit for every $100 of shareholder equity.

-68.12%

ROA

TerrAscend Corp. generates $-14.59 in profit for every $100 in assets, demonstrating efficient asset deployment.

-14.59%

Following the Money - Real Cash Generation

Operating Cash Flow

TerrAscend Corp. produces operating cash flow of $39.43M, showing steady but balanced cash generation.

$39.43M

Free Cash Flow

TerrAscend Corp. generates strong free cash flow of $36.58M, providing ample flexibility for dividends, buybacks, or growth.

$36.58M

FCF Per Share

Each share generates $0.10 in free cash annually.

$0.10

FCF Yield

TRSSF converts 5.23% of its market value into free cash.

5.23%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.37

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.14

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.23

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.31

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.48

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.38

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.68

vs 25 benchmark

ROA

Return on assets percentage

-0.15

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How TRSSF Stacks Against Its Sector Peers

MetricTRSSF ValueSector AveragePerformance
P/E Ratio-6.3728.50 Better (Cheaper)
ROE-68.12%836.00% Weak
Net Margin-31.21%-22564.00% (disorted) Weak
Debt/Equity0.480.30 Weak (High Leverage)
Current Ratio1.384.53 Neutral
ROA-14.59%-14951.00% (disorted) Weak

TRSSF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TerrAscend Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ